<!DOCTYPE html>
<html lang="en">

<head>
  <title>Migraines | The Peripheral Brain</title>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <script src='https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.2/MathJax.js?config=TeX-MML-AM_CHTML'></script>
  <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.3.1/jquery.min.js"></script>

  <link rel="stylesheet" href="/peripheral_brain/css/main.css" />
  <link rel="stylesheet" href="/peripheral_brain/css/mobile.css" />
  <link rel="stylesheet" href="/peripheral_brain/css/buttons.css" />

  
    <link rel="stylesheet" href="/peripheral_brain/css/diseases.css">
  


  <link href="https://fonts.googleapis.com/css?family=Open+Sans" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto+Slab" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto+Mono" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto+Condensed" rel="stylesheet">


  <link rel="apple-touch-icon" sizes="180x180" href="/peripheral_brain/favicons/apple-touch-icon.png">
  <link rel="icon" type="image/png" sizes="32x32" href="/peripheral_brain/favicons/favicon-32x32.png">
  <link rel="icon" type="image/png" sizes="16x16" href="/peripheral_brain/favicons/favicon-16x16.png">
  <link rel="manifest" href="/peripheral_brain/favicons/site.webmanifest">
  <link rel="mask-icon" href="/peripheral_brain/favicons/safari-pinned-tab.svg" color="#465c8b">
  <link rel="shortcut icon" href="/peripheral_brain/favicons/favicon.ico">
  <meta name="apple-mobile-web-app-title" content="Peripheral Brain">
  <meta name="application-name" content="Peripheral Brain">
  <meta name="msapplication-TileColor" content="#da532c">
  <meta name="msapplication-config" content="/peripheral_brain/favicons/browserconfig.xml">
  <meta name="theme-color" content="#cdcdcd">


  

</head>


<body class="body">
<header id="myHeader" class="myHeader">
  <nav>
    <!-- <a href="/peripheral_brain/home.html"><img src="/peripheral_brain/images/logo_1000x1000.png" alt="Logo"> -->
    <a href="/peripheral_brain/home.html">Home</a>
    <a href="/peripheral_brain/disease_list.html">Diseases and Drugs</a>
    <a href="/peripheral_brain/firstFive">TF5M</a>
    <a href="/peripheral_brain/lab_values">Lab Values</a>
    <a href="/peripheral_brain/formulas">Formulas</a>
    <a href="/peripheral_brain/literature.html">Literature</a>
    <a href="/peripheral_brain/abxCalc.html">Calculators</a>
    <a href="/peripheral_brain/search.html">Search</a>
    <a href="javascript:void(0);" class="icon" onclick="openMenu()">&#9776;</a>
  </nav>

  <script>
  function openMenu() {
      var x = document.getElementById("myHeader");
      if (x.className === "myHeader") {
          x.className += " responsive";
      } else {
          x.className = "myHeader";
      }
  }
  </script>
</header>


<h1 class="title">Migraines</h1>

<div class="contents twoCol">
  <div class="toc col1">
    
      <ul>
  <li><a href="#headache-classification">Headache Classification</a></li>
  <li><a href="#pathophysiology">Pathophysiology</a>
    <ul>
      <li><a href="#comorbidities">Comorbidities</a></li>
    </ul>
  </li>
  <li><a href="#dx">Dx</a>
    <ul>
      <li><a href="#auras">Auras</a></li>
      <li><a href="#migraine-variants">Migraine Variants</a></li>
    </ul>
  </li>
  <li><a href="#treatment">Treatment</a>
    <ul>
      <li><a href="#treatment-principles">Treatment Principles</a></li>
      <li><a href="#drugs">Drugs</a></li>
      <li><a href="#prophylaxis">Prophylaxis</a></li>
      <li><a href="#status-migrainosus">Status Migrainosus</a></li>
      <li><a href="#cluster-has">Cluster HAs</a></li>
    </ul>
  </li>
</ul>

    
  </div>

  <div class="content col2">
    <h1 id="headache-classification">Headache Classification</h1>
<ul>
  <li>Primary
    <ul>
      <li>Tension Type
        <ul>
          <li>Tension HA: Bilateral over forehead and neck</li>
          <li>Cervical Osteoarthritis: Neck</li>
          <li>Chronic Myositis: Inflammation of muscle tissue</li>
        </ul>
      </li>
      <li>Vascular Type
        <ul>
          <li>Migraine</li>
          <li>Cluster: Severe, usually w/ autonomic SSx</li>
          <li>Non-Migraine Vascular: Hangovers, HTN, and post-ictal</li>
        </ul>
      </li>
    </ul>
  </li>
  <li>Secondary
    <ul>
      <li>Trauma</li>
      <li>Aneurysm and Vascular Malformations</li>
      <li>Tumor</li>
      <li>Some systemic disorers</li>
      <li>Medication-induced</li>
    </ul>
  </li>
</ul>

<h1 id="pathophysiology">Pathophysiology</h1>
<p>The pathophysiology is not fully elucidated. The current theory is that the primary underlying physiology is an intial vasospasm followed by prolonged vasodilation, leading to inflammation and edema. The current theory of the cause of the vasospasm is a phenomena known as the Cortical Spreading Depression (CSD).
For an unkown reason, areas of high brain activity, often the occipital lobe, can produce a wave-front of decreased cortical function accompanied by increased extracellular K, H+, and NO, leading to activation of nociceptors of the trigeminal nerve (CN-V) innervating the meninges. This promotes the release of CGRP (calcitonin gene-related peptide), Substance-P, and other neuroinflammatory peptides and inflammatory mediators, which results in significant vasodilation and pain.
Relevant 5-HT receptors for migraines include the 5-HT<sub>1B</sub>, 5-HT<sub>1D</sub>, and 5-HT<sub>1F</sub> receptors, which mediate vasoconstriction, inhibition of neurotransmitter release, and inhibition of neuroinflammatory peptides and nociceptive signalling respectively.</p>

<h2 id="comorbidities">Comorbidities</h2>
<ul>
  <li>Depression</li>
  <li>Anxiety Disorders</li>
  <li>Epilepsy</li>
  <li>Stroke</li>
  <li>BPD</li>
  <li>IBS</li>
  <li>CV Dx</li>
  <li>Asthma</li>
  <li>Mitral prolapse</li>
  <li>Raynaud’s Phenomenon</li>
</ul>

<h1 id="dx">Dx</h1>
<ul>
  <li>Migraine w/ Aura
    <ul>
      <li>Minimum of 2 attacks</li>
      <li>Gradual onset</li>
      <li>Aura lasts 5-60min</li>
      <li>HA follows aura w/i 60min</li>
      <li>Normal neuro exam w/ no evidence of other condition inducing HA</li>
    </ul>
  </li>
  <li>Migraine w/o Aura
    <ul>
      <li>Minimum of 5 attacks lasting 4-72hrs</li>
      <li>Any 2 of +…
        <ul>
          <li>Unilateral</li>
          <li>Pulsating</li>
          <li>Aggravated by routine physical activity</li>
          <li>Moderate-Severe</li>
        </ul>
      </li>
      <li>… Any 1 of
        <ul>
          <li>N / V</li>
          <li>Photophobia and Phonophobia</li>
        </ul>
      </li>
      <li>Normal neuro exam w/ no evidence of other condition inducing HA
        <h2 id="auras">Auras</h2>
      </li>
    </ul>
  </li>
  <li>Visual
    <ul>
      <li>Photopsias: Light flashes</li>
      <li>Teichopsias: Bright, shimmering colors</li>
      <li>Scotomas: Blind spot in otherwise normal vision</li>
      <li>Hemiaopias: Blindness in 1/2 field of vision</li>
    </ul>
  </li>
  <li>Sensory
    <ul>
      <li>Unilateral tingling or numbness</li>
      <li>Hemiparesis</li>
      <li>Opthalmoplegia (eye muscle paralysis)</li>
      <li>Dysphasia</li>
      <li>Olfactory Hallucinations</li>
      <li>Vertigo
        <h2 id="migraine-variants">Migraine Variants</h2>
      </li>
    </ul>
  </li>
  <li>Acephalic: Aura w/o HA</li>
  <li>Hemiplegic: One-sided paralysis w/ dysphagia</li>
  <li>Vertebrobasilar: Diplopia, ataxia, vertigo, and incoordination</li>
  <li>Ophthlmoplegic: Eye muscle paralysis lasting days-weeks after HA</li>
  <li>Retinal: Blindness / visual loss returning to baseline after a few hours</li>
</ul>

<h1 id="treatment">Treatment</h1>
<h2 id="treatment-principles">Treatment Principles</h2>
<ul>
  <li>Mild-moderate disease
    <ul>
      <li>Initiate NSAIDs or APAP</li>
      <li>Initiate combination of APAP / ASA / Cafeine if response inadequate</li>
      <li>Initiate Severe therapy if inadequate response</li>
    </ul>
  </li>
  <li>Severe
    <ul>
      <li>Initiate triptans or ergotamines</li>
      <li>Initiate combination therapy if response inadequate</li>
      <li>Sumatriptan, rizatriptan, almotriptan, eletriptan, and zolmitriptan 1st line</li>
      <li>Naratriptan or frovatriptan for better tolerability</li>
      <li>Ergotamine or DHE for infrequent HAs or to decrease cost (but less effective)</li>
    </ul>
  </li>
  <li>Avoid acute therapy to ≤ 2d per week</li>
  <li>Add antiemetics if necessary
    <ul>
      <li>Metoclopramide 10mg</li>
      <li>Consider chlorpromazine, prochlorperazine, or promethazine
        <h2 id="drugs">Drugs</h2>
        <h3 id="nsaids">NSAIDs</h3>
      </li>
    </ul>
  </li>
  <li>ASA 325-1000mg PO q6h PRN NTE 4g QD</li>
  <li>APAP 1000mg PO then 500mg PO q4-6h PRN NTE 3-4g QD
    <ul>
      <li>APAP and metoclopramide is a effective as triptans</li>
    </ul>
  </li>
  <li>Ibuprofen 400-800mg PO NTE 3200mg QD</li>
  <li>Ketoprofen 75mg PO NTE 300mg QD</li>
  <li>Naproxen 750mg PO then 250mg q12h NTE 1250mg QD</li>
  <li>Ketorolac 30-60mg IM/IV NTE 120mg QD
    <h3 id="ergot-alkaloids">Ergot Alkaloids</h3>
    <h4 id="moa">MOA</h4>
    <p>5-HT<sub>2A, 1B, 1D, 1F</sub> receptor agonists, as well as partial α<sub>1</sub> agonists</p>
    <h4 id="drugs-1">Drugs</h4>
  </li>
  <li>Ergonovine</li>
  <li>Ergotamine / Dihydroergotamine (DHE)
    <ul>
      <li>Less likely to cause peripheral vasoconstriction</li>
      <li>Ergotamine 1-2mg PO</li>
      <li>DHE 2mg Intranasal
        <h3 id="triptans">Triptans</h3>
        <h4 id="moa-1">MOA</h4>
        <p>5-HT<sub>1B, 1D, 1F</sub> agonists</p>
        <h4 id="drugs-2">Drugs</h4>
      </li>
    </ul>
  </li>
  <li>Sumatriptan (Imitrex)
    <ul>
      <li>t<sub>1/2</sub>: 2hr</li>
      <li>50-100mg PO</li>
    </ul>
  </li>
  <li>Zolmitriptan (Zomig)
    <ul>
      <li>t<sub>1/2</sub>: 2.8hr</li>
      <li>High ADR rate</li>
      <li>2.5mg PO</li>
    </ul>
  </li>
  <li>Naratriptan (Amerge)
    <ul>
      <li>t<sub>1/2</sub>: 5.5hr</li>
      <li>2.5mg PO</li>
    </ul>
  </li>
  <li>Rizatriptan (Maxalt)
    <ul>
      <li>t<sub>1/2</sub>: 2hr</li>
      <li>Rapid acting</li>
      <li>10mg PO</li>
    </ul>
  </li>
  <li>Almotriptan (Axert)
    <ul>
      <li>t<sub>1/2</sub>: 3.3hr</li>
      <li>Low ADR rates</li>
      <li>12.5mg PO</li>
    </ul>
  </li>
  <li>Eletriptan (Relpax)
    <ul>
      <li>t<sub>1/2</sub>: 4hr</li>
      <li>Very effective, but more common ADRs</li>
      <li>40mg PO</li>
    </ul>
  </li>
  <li>Frovitriptan (Frovan, Miguard)
    <ul>
      <li>t<sub>1/2</sub>: 26hr</li>
      <li>2.5mg PO
        <h3 id="misc">Misc</h3>
      </li>
    </ul>
  </li>
  <li>Isometheptene
    <ul>
      <li>Works better than tryptans in pts which it is effective for, but does not work for all pts</li>
    </ul>
  </li>
</ul>

<h3 id="ses">SEs</h3>
<ul>
  <li>Triptans
    <ul>
      <li>Somnolence</li>
      <li>Nausea</li>
      <li>Dizziness</li>
      <li>Asthenia</li>
      <li>Pain in chest</li>
      <li>Rare
        <ul>
          <li>Coronary vasospasm</li>
          <li>Angina</li>
          <li>V-Tach/Fib</li>
          <li>MI</li>
        </ul>
      </li>
    </ul>
  </li>
  <li>Ergotamines
    <ul>
      <li>Cyanotic extremeties</li>
      <li>Ischemic bowel disease</li>
      <li>N/V</li>
      <li>Peripheral ischemia
        <h3 id="cis">CIs</h3>
      </li>
    </ul>
  </li>
  <li>Triptans
    <ul>
      <li>CVD</li>
      <li>Cerebrovascular disease</li>
      <li>PVD</li>
      <li>Uncontrolled HTN</li>
      <li><strong>Hemiplegic / Basilar Migraines</strong></li>
      <li><strong>Use w/ SSRIs/SNRIs due to risk of serotonin syndrome</strong>
        <ul>
          <li>Caution w/ other serotinergic agents</li>
        </ul>
      </li>
    </ul>
  </li>
  <li>Ergotamines
    <ul>
      <li>Same as triptans</li>
      <li>Renal impairment</li>
      <li>Hepatic disease</li>
      <li>Glaucoma</li>
      <li><strong>Pregnancy</strong>
        <h2 id="prophylaxis">Prophylaxis</h2>
      </li>
    </ul>
  </li>
  <li>1st Line
    <ul>
      <li>β-Blockers (propranolol or timolol)
        <ul>
          <li>Propranolol LA 90mg PO QD, then BID, then TID if needed</li>
          <li>Timolol 10mg PO BID then 20mg PO QD after one month, then 15mg PO BID if needed</li>
          <li>Atenolol, metoprolo, and bisoprolol can be used if pt needs cardioselective β-blocker, or verapamil can be used</li>
          <li>If HA frequency has not changed in 8wks, taper and D/C</li>
        </ul>
      </li>
      <li>Topiramate
        <ul>
          <li>Initiate 25mg PO QD, then increase by 25mg weekly to 100-200mg QD</li>
          <li>Some evidence</li>
        </ul>
      </li>
      <li>TCAs
        <ul>
          <li>Amitriptyline 25-300mg QD</li>
          <li>Doxepin 10-150mg QD</li>
          <li>Start low and titrate</li>
          <li>Drug of choice for mixed headache syndrome (2-8 migraines monthly w/ daily tension HA)</li>
        </ul>
      </li>
      <li>Valproate</li>
      <li>Extended-cycle OCs if menstruation related</li>
    </ul>
  </li>
  <li>Give in order listed above, unless co-morbid illness (such as depression for TCAs) exists</li>
  <li>2nd Line (Off-Label)
    <ul>
      <li>CCBs (verapamil)</li>
      <li>ACEIs/ARBs</li>
      <li>Valproate</li>
      <li>Gabapentin</li>
      <li>ASA</li>
      <li>α<sub>1</sub> Antagonists</li>
      <li>Trazodone</li>
      <li>Botox</li>
      <li>Quetiapine</li>
      <li>Memantine</li>
    </ul>
  </li>
</ul>

<h2 id="status-migrainosus">Status Migrainosus</h2>
<ul>
  <li>Critera: &gt; 72hr w/ or w/o tretment</li>
  <li>Sumatriptan 6mg SubQ w/ anti-emetic and IV fluids</li>
  <li>Consider DHE 1mg SubQ, Ketorolac 30mg IV, and/or steroids</li>
</ul>

<h2 id="cluster-has">Cluster HAs</h2>
<ul>
  <li>1st Line
    <ul>
      <li>Sumatriptan 6mg SubQ, 20mg intranasal</li>
      <li>O2 100% @ 7-10 L/min</li>
      <li>Meperidine 50-100mg IM or other opioid</li>
      <li>Cocaine 10% 0.5mL intranasal</li>
      <li>DHE</li>
    </ul>
  </li>
  <li>2nd Line
    <ul>
      <li>Sumatriptan 25mg NTE 100mg or equivalent</li>
      <li>Ergotamine 2mg SL</li>
      <li>DHE 1mg IM or SubQ</li>
    </ul>
  </li>
  <li>Prevention
    <ul>
      <li>Trial off drugs q3-4wks w/o HA</li>
      <li>Capsaicin 0.03% intranasal</li>
      <li>Divalproex</li>
      <li>Verapamil</li>
      <li>Li</li>
      <li>Nifedipine</li>
      <li>Baclofen</li>
      <li>Ergotamine</li>
      <li>Topiramate</li>
      <li>GCs</li>
      <li>Lidocaine 4% intranasal</li>
      <li>Gabapentin</li>
    </ul>
  </li>
</ul>

  </div>

</div>

<div class="credits">
  <p>Author: Corbin Cox <br>
  Created: 2018-8-16 <br>
  Last Updated: 2018-8-16</p>
</div>

<footer class="footer menus">
  <nav>
    <div class="footerLinks">
      <a href="/peripheral_brain/home.html">Home</a>
      <a href="/peripheral_brain/index.html">Disclaimer</a>
      <a href="/peripheral_brain/disease_list_old.html">Archived Diseases</a>
    </div>
  </nav>
</footer>


</body>
</html>
